← FDATracker
HomeAdverse Events

EXJADE Adverse Event: Neoplasm progression

EXJADE Adverse Event: Neoplasm progression is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: EXJADE; Product category: Drug; Primary reaction: Neoplasm progression.

Primary drugEXJADE
Product categoryDrug
Primary reactionNeoplasm progression
All reactionsNeoplasm progression
SeriousnessSerious
Patient outcomeUnknown
Patient sexMale
All drugs reportedEXJADE
Reporter countryCOUNTRY NOT SPECIFIED
Reporter type5
Report date20140312
Report ID10004178

🔍 Search all adverse events →